[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366240-105":59,"doc-detail-366240-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","arl6ip5-in-cancers-bidirectional-function-and-therapeutic-value","ARL6IP5 in cancers: bidirectional function and therapeutic value","","ARL6IP5 (ADP-ribosylation-like factor 6 interacting protein 5) is summarized as a cancer-associated regulator with controversial, context-dependent roles. The review compiles evidence that ARL6IP5 can act as a tumor suppressor in many cancers, while functioning as an oncogene in specific contexts, including chronic hepatitis virus-related hepatocellular carcinoma. It highlights mechanistic links to pathways such as glutamate transport, oxidative stress, autophagy, and DNA damage repair, and evaluates therapeutic value for cancer treatment strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/arl6ip5-in-cancers-bidirectional-function-and-therapeutic-value/366240/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/arl6ip5-in-cancers-bidirectional-function-and-therapeutic-value/366240.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are ARL6IP5 roles in cancers described as bidirectional?","Question",{"text":112,"@type":113},"The review explains that ARL6IP5 can show opposite functional effects depending on cancer type and biological context. Public expression data and representative studies indicate context-dependent overexpression or down-regulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does ARL6IP5 relate to liver cancer and chronic hepatitis virus-related disease?",{"text":117,"@type":113},"In liver cancer, ARL6IP5 is described as being more involved in the pathogenesis of hepatitis C virus (HCV)-related cancers. The review emphasizes chronic hepatitis virus-related hepatocellular carcinoma as a key area.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological processes are implicated in ARL6IP5 function relevant to cancer?",{"text":121,"@type":113},"ARL6IP5 is linked to glutamate transportation, oxidative stress, autophagy, and DNA damage repair. These pathways provide mechanistic foundations for its tumor-suppressing or oncogenic behavior.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366240,1791069732,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www.nature.com/cgt](www.nature.com/cgt) Cancer Gene Therapy  \nREVIEW ARTICLE OPEN   \nARL6IP5 in cancers: bidirectional function and therapeutic value  \nZenan Hu 1,2,3,5, Hanxun Yue 1,2,3,5 and Liang Qiao 4 ✉  \n© The Author(s) 2025, corrected publication 2025  \n\n|  | ARL6IP5 (ADP-ribosylation-like factor 6 interacting protein 5) plays an important role in a variety of physiological or pathological processes, including in cancers. However, the biological roles of ARL6IP5 in cancers are controversial. In this mini-review, we summarized the current understanding on the role of ARL6IP5 in cancers, particularly in the progression of chronic hepatitis virus- |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n| related hepatocellular carcinoma, as well as the potential values of ARL6IP5 in cancer therapy. |  |  |\n|  | Cancer Gene Therapy (2025) 32:744–749; [https://doi.org/10.1038/s41417-025-00903-x](https://doi.org/10.1038/s41417-025-00903-x) |  |\n|  |  |  |\n\nINTRODUCTION  \nCancer is a leading cause of death worldwide, creating asigniﬁcant health, social, and economic burdens [1–3] . Cancerrelated deaths have increased by 25.4% worldwide per year between 2007 and 2017 [4] . The absolute disability-adjusted life years of cancer have increased by 20.9% during 2010 to 2019 [5] . Understanding the molecular pathogenesis of cancers is a prerequisite for developing more efﬁcient anti-cancer therapies.  \nAccumulation of multiple genetic alterations and the complex interactions between oncogenes and tumor suppressor genes play important roles in cancer development [6–9] . Identiﬁcation of key driver genes for cancer formation can facilitate the development of targeted therapies.  \nADP-ribosylation-like factor 6 interacting protein 5 (ARL6IP5, also known as JWA, DER11, GTRAP3-18, or HSPC127) was initially cloned from all-trans-retinoic acid (ATRA)-treated human bronchial epithelial cells, but was later found to be ubiquitously expressed in most of the human tissues [10] . The gene encoding ARL6IP5 is located at chromosome 3p, and its protein is localized to endoplasmic reticulum (ER) and Golgi apparatus. ARL6IP5 is a homolog of Drosophila PRAF2, a small protein from the prenylated Rab acceptor family that plays a role in ER-to-Golgi transport [11] . The rodent homologs of ARL6IP5, addicsin in mice and glutamate transporter-associated protein 3-18 (GTRAP3-18) in rats, are abundantly present in the brain and play important roles in neuronal differentiation and glutathione regulation [12–16] .  \nARL6IP5 is involved in the regulation of multiple physiological and pathological processes, such as glutamate transportation, oxidative stress, autophagy, and DNA damage repair [17–22] . Publicly available Gene Expression Proﬁling Interactive Analysis (GEPIA) dataset ([gepia.cancer-pku.cn](gepia.cancer-pku.cn)) reveals an overexpression of ARL6IP5 in the cancer tissues originating from lymph, brain, kidney, blood, pancreas, skin, and thymus, relative to their respective normal tissues. However, in other cancer tissues including those from bladder cancer, squamous carcinoma of the cervix, squamous cell lung carcinoma, endometrial cancer, and  \nsarcoma of the uterus, a down-regulation of ARL6IP5 was observed. These data indicate that the roles of ARL6IP5 in cancers may be bidirectional and context-dependent.  \nAs shown in Table 1, the role of ARL6IP5 in human cancers is mixed and contradictory: it functions as a tumor suppressor inmost cancers, but in some cancers, it acts as an oncogene. The biological functions of ARL6IP5 may depend on many factors such as tumor microenvironment and etiological factors. For example, in liver cancer, ARL6IP5 is more involved in the pathogenesis of hepatitis c virus (HCV)-related cancers.  \nIn this article, we aim to provide an overview of the consensus and controversies of the roles of ARL6IP5 in human cancers. Thereview provides valuable insights in the search for novel therapeutic strategies for cancers.  \nARL6IP5 PLAYS BI","cbCaiowfwgvxU3oM","https://ap.wps.com/l/cbCaiowfwgvxU3oM","pdf",663501,"English","# Introduction\n# ARL6IP5 plays bidirectional roles in different cancers\n## Tumor suppressor roles across cancers\n## Contradictory oncogenic roles in specific cancers\n# Therapeutic value and future directions","[{\"question\":\"Why are ARL6IP5 roles in cancers described as bidirectional?\",\"answer\":\"The review explains that ARL6IP5 can show opposite functional effects depending on cancer type and biological context. Public expression data and representative studies indicate context-dependent overexpression or down-regulation.\"},{\"question\":\"How does ARL6IP5 relate to liver cancer and chronic hepatitis virus-related disease?\",\"answer\":\"In liver cancer, ARL6IP5 is described as being more involved in the pathogenesis of hepatitis C virus (HCV)-related cancers. The review emphasizes chronic hepatitis virus-related hepatocellular carcinoma as a key area.\"},{\"question\":\"What biological processes are implicated in ARL6IP5 function relevant to cancer?\",\"answer\":\"ARL6IP5 is linked to glutamate transportation, oxidative stress, autophagy, and DNA damage repair. These pathways provide mechanistic foundations for its tumor-suppressing or oncogenic behavior.\"}]","ARL6IP5 in cancers: bidirectional function and therapeutic value | PDF",1790164353,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7d6b17cdc7b44e43b69d48fe47c4827.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12824e3de8230c6e31af11871ef3d6ef.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bb61b2913dd9f77686dd8868a161b7c.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/447e7abce980ea411bc67ff926a5edc7.webp",980,1301]